Novel Intranasal Replication-Deficient NS1ΔC Flu Vaccine Confers Protection from Divergent Influenza A and B Viruses in Mice
Daria Shamakova, Marina A. Shuklina, Nikita Yolshin, Ekaterina Romanovskaya-Romanko, Anna-Polina Shurygina, Kira Kudrya, Arman Muzhikyan, Mariia V. Sergeeva, Marina Stukova · 2025
Read Novel Intranasal Replication-Deficient NS1ΔC Flu Vaccine Confers Protection from Divergent Influenza A and B Viruses in Mice by Daria Shamakova, Marina A. Shuklina, Nikita Yolshin, Ekaterina Romanovskaya-Romanko, Anna-Polina Shurygina, Kira Kudrya, Arman Muzhikyan, Mariia V. Sergeeva, Marina Stukova (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12846425.txt.
Description
Daria Shamakova and eight co-authors wrote a 2025 study on a nasal flu vaccine designed to protect across strains. Seasonal flu vaccines are rebuilt yearly because the virus drifts, and their cross-protection is weak. Viruses missing part of their NS1 protein are known to rouse broad T-cell defenses instead.
The team engineered influenza A and B viruses with the NS1 tail deleted, so they cannot replicate fully. A single B strain given through the nose was safe in mice and woke cross-reactive T cells in the lungs. It protected against distinct B lineages. A three-strain mix then faced lethal challenges from matched, mismatched, and drifted A and B viruses. The vaccine conferred protection across that range. A universal flu shot is the long-term prize.
Catalog record
| CREATOR | Daria Shamakova, Marina A. Shuklina, Nikita Yolshin, Ekaterina Romanovskaya-Romanko, Anna-Polina Shurygina, Kira Kudrya, Arman Muzhikyan, Mariia V. Sergeeva, Marina Stukova |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |